Altobelli Emanuela, Buscarini Maurizio, Gill Harcharan S, Skinner Eila C
Department of Urology, Campus Biomedico University of Rome , Rome, Italy.
Department of Urology, Stanford University School of Medicine , Stanford, CA, USA.
Bladder Cancer. 2017 Jan 27;3(1):51-56. doi: 10.3233/BLC-160061.
Radical cystectomy (RC) is associated with high risk of early and late perioperative complications, and readmissions. The Enhanced Recovery After Surgery (ERAS) protocol has been applied to RC showing decreased hospital stay without increased morbidity. To evaluate the specific causes of hospital readmissions in RC patients treated before and after adoption of an ERAS protocol at our institution. We retrospectively evaluated the outcome of 207 RC patients on ERAS protocol at the Stanford University Hospital from January 2012 to December 2014. We focused on early (30-day) and late (90-day) postoperative readmission rate and causes. Results were compared with a pre-ERAS consecutive series of 177 RC patients from January 2009 to December 2011. In the post-ERAS time period a total of 56 patients were readmitted, 41 within the first 30 days after surgery (20%) and 15 within the following 60 days (7%). Fever, often associated with dehydration, was the most common reason for presentation to the hospital, accounting for 57% of all readmissions. At 90 days infection accounted for 53% of readmissions. Of all the patients readmitted during the first 90 days after surgery, 32 had positive urine cultures, mostly caused by Enterococcus faecalis isolated in 18 (56%). Readmission rates did not increase since the introduction of the ERAS protocol, with an incidence of 27% in the post-ERAS group versus 30% in the pre-ERAS group. Despite accurate adherence to most recent perioperative antibiotic guidelines, the incidence of readmissions after RC due to infection still remains significant.
根治性膀胱切除术(RC)与围手术期早期和晚期并发症及再入院的高风险相关。术后加速康复(ERAS)方案已应用于RC,结果显示住院时间缩短且发病率未增加。为了评估在我们机构采用ERAS方案前后接受治疗的RC患者再次入院的具体原因。我们回顾性评估了2012年1月至2014年12月在斯坦福大学医院接受ERAS方案治疗的207例RC患者的结局。我们重点关注术后早期(30天)和晚期(90天)再入院率及原因。将结果与2009年1月至2011年12月接受ERAS方案前连续的177例RC患者进行比较。在ERAS方案实施后的时间段内,共有56例患者再次入院,其中41例在术后前30天内(20%),15例在接下来的60天内(7%)。发热,通常与脱水有关,是再次入院最常见的原因,占所有再入院病例的57%。在90天时,感染占再入院病例的53%。在术后前90天内再次入院的所有患者中,32例尿培养呈阳性,主要由粪肠球菌引起,其中18例(56%)。自引入ERAS方案以来,再入院率并未增加,ERAS方案实施后组的发生率为27%,而ERAS方案实施前组为30%。尽管严格遵守了最新的围手术期抗生素指南,但RC术后因感染导致的再入院发生率仍然很高。